Kanser Tedavisinde Güncel Yaklaşimlar O Baykara Balıkesir Sağlık Bilimleri Dergisi 5 (3), 154-165, 2016 | 148 | 2016 |
Association between interleukin-1 beta (IL-1β) gene polymorphism and outcome after head injury: an early report M Uzan, T Tanriverdi, O Baykara, A Kafadar, GZ Sanus, E Tureci, ... Acta neurochirurgica 147, 715-720, 2005 | 63 | 2005 |
Current modalities in treatment of cancer O Baykara Balıkesır Health Sciences Journal 5 (3), 154-165, 2016 | 51 | 2016 |
Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy M Niyazoglu, O Baykara, A Koc, P Aydoğdu, I Onaran, FD Dellal, E Tasan, ... Gene 547 (2), 226-232, 2014 | 47 | 2014 |
Amplification of chromosome 8 genes in lung cancer O Baykara, B Bakir, N Buyru, K Kaynak, N Dalay Journal of cancer 6 (3), 270, 2015 | 43 | 2015 |
Lack of association between IL-1β/α gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis C Ozkara, M Uzan, T Tanriverdi, O Baykara, B Ekinci, N Yeni, A Kafadar, ... Seizure 15 (5), 288-291, 2006 | 40 | 2006 |
Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis SN Yeni, Ç Özkara, N Buyru, O Baykara, L Hanoğlu, N Karaağac, ... European journal of neurology 12 (2), 103-107, 2005 | 40 | 2005 |
WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC) O Baykara, A Demirkaya, K Kaynak, S Tanju, A Toker, N Buyru Tumor Biology 31, 315-320, 2010 | 37 | 2010 |
Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury T Tanriverdi, M Uzan, GZ Sanus, O Baykara, M Is, C Ozkara, N Buyra Surgical neurology 65 (1), 7-10, 2006 | 37 | 2006 |
LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus B Aydemir, O Baykara, FBS Cinemre, H Cinemre, A Tuten, AR Kiziler, ... Archives of gynecology and obstetrics 293, 517-527, 2016 | 27 | 2016 |
ZNF 703 Overexpression may act as an oncogene in non‐small cell lung cancer O Baykara, N Dalay, K Kaynak, N Buyru Cancer medicine 5 (10), 2873-2878, 2016 | 25 | 2016 |
Association of epidermal growth factor receptor and K‑Ras mutations with smoking history in non‑small cell lung cancer patients O Baykara, M Tansarikaya, A Demirkaya, K Kaynak, S Tanju, A Toker, ... Experimental and therapeutic medicine 5 (2), 495-498, 2013 | 23 | 2013 |
The impact of prothrombotic mutations on factor consumption in adult patients with severe hemophilia MC Ar, O Baykara, AN Buyru, Z Baslar Clinical and Applied Thrombosis/Hemostasis 15 (6), 660-665, 2009 | 21 | 2009 |
CHD5 is a potential tumor suppressor in non small cell lung cancer (NSCLC) O Baykara, M Tansarikaya, P Bulut, A Demirkaya, N Buyru Gene 618, 65-68, 2017 | 17 | 2017 |
The EMSY gene collaborates with CCND1 in non-small cell lung carcinogenesis O Baykara, N Dalay, B Bakir, P Bulut, K Kaynak, N Buyru International Journal of Medical Sciences 14 (7), 675, 2017 | 13 | 2017 |
Current therapies and latest developments in cancer treatment O Baykara Horizons in Cancer Research 57, 105-156, 2015 | 13 | 2015 |
The effects of mitochondrial DNA deletion and copy number variations on different exercise intensities in highly trained swimmers O Baykara, SK Sahin, F Akbas, M Guven, I Onaran Cellular and Molecular Biology 62 (12), 109-115, 2016 | 12 | 2016 |
CT120: a new potential target for c-Myc in head and neck cancers E Baltaci, B Seyhan, O Baykara, N Buyru Journal of Cancer 8 (5), 880, 2017 | 8 | 2017 |
Monitoring of platelet function parameters and microRNA expression levels in patients with prostate cancer treated with volumetric modulated arc radiotherapy N Bahtiyar, İ Onaran, B Aydemir, O Baykara, S Toplan, FY Agaoglu, ... Oncology Letters 16 (4), 4745-4753, 2018 | 6 | 2018 |
VDBP gene polymorphism in COPD S Soyyigit, O Baykara, N Buyru, M Erk, S SOYYİGİT, O BAYKARA, ... Medicine Science 2 (1), 403-413, 2013 | 5 | 2013 |